Oragenics Inc (OGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,107 | 4,400 | 11,404 | 1,974 | 3,421 |
| Marketable Securities | N/A | 4,000 | N/A | N/A | N/A |
| Receivables | N/A | 53 | N/A | N/A | N/A |
| TOTAL | $7,490 | $10,068 | $12,706 | $2,140 | $3,869 |
| Non-Current Assets | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $7,490 | $10,068 | $12,706 | $2,140 | $3,869 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,252 | 1,559 | 2,479 | 1,267 | 1,177 |
| TOTAL | $1,308 | $1,786 | $2,874 | $4,267 | $3,731 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,308 | $1,786 | $2,874 | $4,267 | $3,731 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 4,512 | 4,336 | 4,168 | 4,127 | 715 |
| Common Shares | 4 | 4 | 4 | 1 | 22 |
| Retained earnings | -228,830 | -226,629 | -224,342 | -221,275 | -219,003 |
| TOTAL | $6,182 | $8,281 | $9,831 | $-2,128 | $138 |
| Total Liabilities And Equity | $7,490 | $10,068 | $12,706 | $2,140 | $3,869 |